Name | Lorvotuzumab |
---|
Description | Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1]. |
---|---|
Related Catalog | |
In Vitro | Lorvotuzumab mertansine (IMGN901) 是一种 ADC,可通过二硫键连接强效抗有丝分裂 (DM1) 与 CD56 靶向抗体 (Lorvotuzumab)。 Lorvotuzumab mertansine 抗肾母细胞瘤、横纹肌肉瘤和神经母细胞瘤。 |
References |
No Any Chemical & Physical Properties |